Clinical and pathological data of 10 malignant pheochromocytomas: Long-term follow up in a single institute

International Journal of Urology

Volumn 14, Issue 3, 2007, Pages 181-185

  Huang, Kuo How ^a   Chung, Shiu Dong ^a   Chen, Shyh Chyan ^a   Chueh, Shih Chieh ^a   Pu, Yeong Shiau ^a   Lai, Ming Kuen ^a   Lin, Wei Chou ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adrenal gland neoplasms; Malignant pheochromocytoma; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADULT; ARTICLE; BLADDER TUMOR; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHROMAFFIN SYSTEM; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; PATHOLOGY; PHEOCHROMOCYTOMA; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT DURATION;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS;

EID: 33947193402     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01687.x     Document Type: Article

References (20)

1. Edstrom EE, Hjelm Skog AL, Hoog A, Hamberger B. The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Eur. J. Surg. Oncol. 2003; 29: 278-83.
2. Eisenhofer G, Bornstein SR, Brouwers FM et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr. Relat. Cancer 2004; 11: 423-36.
3. Linnoila RI, Keiser HR, Steinberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum. Pathol. 1990; 21: 1168-80.
4. Schlumberger M, Gicquel C, Lumbroso J et al. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J. Endocrinol. Invest. 1992; 15: 631-42.
5. Lenders JW, Pacak K, Walther MM et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287: 1427-34.
6. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam. Cancer 2005; 4: 61-8.
7. Mornex R, Badet C, Peyrin L. Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990. J. Endocrinol. Invest. 1992; 15: 643-9.
8. Shapiro B, Gross MD, Shulkin B. Radioisotope diagnosis and therapy of malignant pheochromocytoma. Trends Endocrinol. Metab. 2001; 12: 469-75.
9. Furuta N, Kiyota H, Yoshigoe F, Hasegawa N, Ohishi Y. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy. Int. J. Urol. 1999; 6: 119-24.
10. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J. Natl. Cancer Inst. 2003; 95: 1196-204.
11. Boltze C, Mundschenk J, Unger N et al. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. J. Clin. Endocrinol. Metab. 2003; 88: 4280-6.
12. Lehnert H, Mundschenk J, Hahn K. Malignant pheochromocytoma. Front. Horm. Res. 2004; 31: 155-62.
13. Proye C, Vix M, Goropoulos A, Kerlo P, Lecomte-Houcke M. High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. J. Endocrinol. Invest. 1992; 15: 651-63.
14. Mahoney EM, Harrison JH. Malignant pheochromocytoma: clinical course and treatment. J. Urol. 1977; 118: 225-9.
15. Guo JZ, Gong LS, Chen SX, Luo BY, Xu MY. Malignant pheochromocytoma: diagnosis and treatment in fifteen cases. J. Hypertens. 1989; 7: 261-6.
16. Yoshida S, Hatori M, Noshiro T, Kimura N, Kokubun S. Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma. Arch. Orthop. Trauma Surg. 2001; 121: 598-600.
17. Schvartz C, Gibold C, Vuillemin B, Delisle MJ. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma. J. Nucl. Biol. Med. 1991; 35: 305-7.
18. Tada K, Okuda Y, Yamashita K. Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia. Horm. Res. 1998; 49: 295-7.
19. Keiser HR, Goldstein DS, Wade JL, Douglas FL, Averbuch SD. Treatment of malignant pheochromocytoma with combination chemotherapy. Hypertension 1985; 7: I18-24.
20. Sisson JC, Shapiro B, Beierwaltes WH et al. Radiopharmaceutical treatment of malignant pheochromocytoma. J. Nucl. Med. 1984; 25: 197-206.